The Longevity Boom: What’s Actually Backed by Science (And What’s Just Good Marketing)

From the physicians at Reve Health Institute

Walk into any wellness expo, scroll through social media, or browse a longevity clinic’s menu of services, and you’ll find no shortage of options promising to slow aging, boost energy, and optimize your biology. Red light panels. Cold plunge tubs. Hyperbaric oxygen chambers. Stem cell injections. IV vitamin drips. Hormone “optimization.” Peptides. Plasma exchange. Vagus nerve devices.

Americans are spending real money on all of it – often thousands of dollars a month. But here’s the question we get asked most often at Reve Health Institute: which of these interventions are actually supported by science, and which are riding the wave of a good marketing campaign?

The honest answer is: it depends on the therapy, the claim being made, and who’s making it. Below, we break down the evidence – clearly and without the hype – so you can make informed decisions about where to spend your time, money, and trust.

Red Light Therapy: Real Science, Overextended Claims

Red light therapy, or photobiomodulation, has legitimate research behind it – but for a narrower set of uses than most marketing suggests. Randomized trials support modest benefits for wound healing, certain inflammatory skin conditions, and mild joint pain. Where the science gets shakier is the broader “anti-aging” and “cellular energy” language used to sell at-home panels. Those claims often stretch small studies or animal research into promises that haven’t been demonstrated in large, well-controlled human trials.

Bottom line: Useful for specific, targeted purposes. Skeptical of sweeping systemic claims.

Hyperbaric Oxygen Therapy (HBOT): Proven for Some, Unproven for Most

HBOT has decades of solid evidence for specific medical conditions: decompression sickness, carbon monoxide poisoning, certain non-healing wounds, and radiation injury. These are FDA-cleared indications. What’s newer – and far less established – is HBOT marketed as a general performance or longevity tool for healthy adults. That use is based mostly on small, preliminary studies, and it isn’t without risk: oxygen toxicity and barotrauma, while uncommon, are real considerations.

Bottom line: A powerful medical therapy for the right diagnosis. Weak evidence as a general wellness tool.

Cold Plunges: Good for Recovery and Mood, Overstated for Everything Else

Cold water immersion has reasonably good evidence for reducing perceived muscle soreness after exercise and for short-term mood benefits, likely tied to a norepinephrine response. The evidence thins out considerably for bigger claims – long-term metabolic boosts, “detoxification,” or lifespan extension. There’s also a nuance worth knowing: some research suggests jumping into cold water immediately after strength training may actually blunt muscle-building adaptations. The right answer often depends on your specific goal.

Bottom line: Legitimate short-term benefits. Not a longevity intervention on its own.

Stem Cells and Exosomes: Where Caution Matters Most

This is an area where we urge real caution. Stem cell therapy has legitimate, FDA-approved uses – primarily in certain blood cancers and disorders of the blood and immune system, through bone marrow and cord blood transplants. But most clinics offering stem cell injections for joint pain, anti-aging, or general wellness are operating outside FDA-approved indications, often using products that aren’t well characterized. The FDA has issued public warnings about unproven stem cell clinics for this exact reason.

Exosomes are even earlier-stage. They’re being marketed aggressively, but there is no FDA-approved exosome product for the anti-aging or wellness claims currently being made. This is a case where the marketing is genuinely ahead of the science.

Bottom line: Approach with significant skepticism outside of established medical indications.

Regenerative Protein Arrays (RPA) and Therapeutic Plasma Exchange (TPE): Two Different Places on the Evidence Spectrum

These two therapies are worth discussing together, because they sit in very different places scientifically.

RPA is a newer, proprietary product – a concentrated, cell-free mixture of proteins, growth factors, and cytokines, often derived from placental tissue, marketed as an alternative to stem cells or PRP. Right now, independent, peer-reviewed clinical evidence in humans is minimal. Most of what’s publicly available is company-produced material and clinic marketing rather than data published in peer-reviewed journals. That doesn’t mean it’s ineffective – but it does mean patients are largely being asked to trust manufacturer claims rather than independently replicated science.

TPE, on the other hand, is a genuinely FDA-approved, decades-old procedure with well-established uses in autoimmune and neurological disease. What’s new is the longevity angle: emerging research, including a controlled trial published in a peer-reviewed aging journal, has shown that removing and replacing plasma can measurably lower biological age markers over several months. That’s a real and interesting signal – but it’s important to be precise. TPE is FDA-approved as a medical procedure, not specifically for anti-aging. Its use for longevity remains investigational, the studies are still small, and long-term outcomes haven’t been established.

Bottom line: RPA is largely unproven outside company claims. TPE is a legitimate medical procedure with promising, early-stage longevity research – but it isn’t an approved anti-aging treatment yet.

Hormone Therapy: Powerful When Diagnosed, Risky When Guessed

Hormone therapy has strong evidence when used to treat a diagnosed deficiency – menopausal hormone therapy for appropriate candidates, or testosterone replacement for men with clinically confirmed hypogonadism, for example. The evidence weakens considerably once you move into “optimization” for otherwise healthy people chasing performance or anti-aging benefits. Long-term safety data in that context is limited, and hormones are powerful enough that using them without a clear diagnosis and ongoing monitoring carries real risk, including cardiovascular and, in some cases, cancer-related concerns depending on the hormone and individual risk factors.

Bottom line: Get tested and diagnosed first. Treatment should follow evidence, not the other way around.

Supplements: The Problem Is Regulation as Much as Science

In the U.S., supplements are regulated more like food than medication – companies don’t have to prove efficacy before selling a product, and manufacturing oversight varies. Some supplements do have solid evidence: vitamin D for people with documented deficiency, omega-3s for certain cardiovascular markers, creatine for muscle performance. But a large share of what’s marketed – especially proprietary “longevity blends” – either hasn’t been tested in rigorous human trials or has been tested with results that don’t match the marketing.

Bottom line: Ask what the specific ingredient has been shown to do, in what population, and at what dose – not what the label promises.

IV Infusions: Convenient, But Often Unnecessary

For most healthy people, IV vitamin infusions offer limited proven benefit beyond a normal diet or oral supplementation, because a healthy gut absorbs nutrients quite well when you’re not deficient. IV administration makes clinical sense in specific situations – documented deficiencies, certain GI conditions that impair absorption, or medical dehydration. Outside of that, you’re often paying a premium for a delivery method your body doesn’t necessarily need, and IV administration carries its own, if uncommon, risks: infection, vein irritation, and electrolyte imbalances.

Bottom line: Helpful for documented deficiencies. Unproven as a routine wellness ritual.

Vagus Nerve Stimulation: Strong Evidence in One Lane, Speculative in Another

Implanted vagus nerve stimulation devices are FDA-approved and well-studied for drug-resistant epilepsy and treatment-resistant depression – that’s solid, peer-reviewed territory. Non-invasive versions, like transcutaneous ear or neck stimulation, have promising early research for heart rate variability, inflammation markers, and stress response. What’s not yet well-supported is the broader wellness marketing around general anti-aging, cognitive enhancement, or immune “optimization” in healthy people. The mechanism is biologically plausible – which is part of why it’s exciting – but plausible mechanism and proven outcome are two different things.

Bottom line: Proven for specific medical conditions. Promising but early for general wellness use.

How to Actually Navigate the Longevity Space

At Reve Health Institute, we don’t think the answer is to avoid this space altogether – some of it is genuinely promising science, and the field is moving quickly. Our advice is to apply three filters before you invest your time or money:

1. What is this therapy actually FDA-approved or clinically validated for – and does that match what you’re being sold it for?
2. Who is publishing the evidence? Independent, peer-reviewed research is very different from a company’s own marketing materials or patient testimonials.
3. Have you talked to a physician who isn’t the one selling you the treatment? Many of these interventions carry real financial cost, and some – hormone therapy, stem cells, plasma exchange – carry genuine medical risk if used without proper diagnosis, dosing, and monitoring.

Awareness only helps if it turns into informed action. That means asking better questions, looking for real evidence, and working with a qualified clinician – not just following what’s trending.